Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
StemCultures is a private life science tools company focused on controlled-release growth factor technologies for cell culture. The company commercializes StemBeads and DISC devices, which are designed to stabilize and sustain growth factor exposure in culture systems to improve consistency, efficiency, and cell quality. Its products are positioned for use in stem cell research, organoid workflows, primary cell culture, and cell manufacturing settings. StemCultures appears to operate as a research tools and enabling technology company rather than a therapeutics developer, so it does not have a traditional drug pipeline. The technology originated from work associated with the Neural Stem Cell Institute and has also been featured through NIH SEED and SBIR/STTR-related materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on StemCultures.